United States Image-Guided Biopsy Market expected to grow at a CAGR of 5.49% during 2023-2030 | Major Compnies 2026 - Koninklijke Philips N.V, Siemens Healthcare GmbH, GE Healthcare | Exclusive report by DataM Intelligence

Leander, Texas and Tokyo, Japan - Jan.08.2026
As per DataM intelligence research report" Image-Guided Biopsy Market is growing at a CAGR of 5.49 % during the forecast period (2023-2030)." Precision diagnostics and minimally invasive procedures are accelerating adoption.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/image-guided-biopsy-market?prasad

United States Recent Industry Developments

✅ In November 2025, Hologic launched the "Brevera 2" breast biopsy system with real-time imaging The system streamlines tissue acquisition and verification into a single step It reduces procedure time and patient anxiety in U.S. breast centers

✅ In October 2025, BrainSpec received FDA clearance for its virtual biopsy software The software uses magnetic resonance spectroscopy to analyze brain tumors non-invasively It reduces the need for high-risk surgical biopsies in U.S. neurology patients

✅ In September 2025, Medtronic introduced a new navigation system for lung biopsy The system uses electromagnetic tracking to guide needles to small peripheral nodules It improves the diagnostic yield for early-stage lung cancer in the U.S.

✅ In August 2025, A U.S. startup released a robotic arm for ultrasound-guided prostate biopsy The robot stabilizes the probe to ensure precise sampling of suspicious areas It standardizes outcomes in U.S. urology clinics

Japan Recent Industry Developments

✅ In December 2025, Canon Medical Systems released an AI-assisted ultrasound for liver biopsy guidance The AI highlights the optimal needle path to avoid blood vessels It enhances safety for patients with advanced liver disease in Japan

✅ In November 2025, Olympus Corporation launched a new endoscopic ultrasound (EUS) needle The needle design allows for acquiring larger core tissue samples for genomic testing It supports the era of precision oncology in Japanese gastroenterology

✅ In October 2025, Fujifilm developed a fusion imaging system for MRI-guided biopsy The system overlays MRI data onto real-time ultrasound for precise targeting It improves the detection of clinically significant prostate cancer in Japan

✅ In September 2025, A Japanese university hospital tested a remote-controlled biopsy robot The system allows specialists in Tokyo to perform biopsies on patients in rural areas It addresses the disparity in specialized medical care in Japan

Image-Guided Biopsy Market: Drivers
The image-guided biopsy market is expanding due to rising cancer incidence and need for accurate diagnosis. Advanced imaging technologies improve precision and reduce procedural risks. Growing adoption of minimally invasive procedures drives demand. Expansion of diagnostic centers supports market growth. Technological innovations enhance workflow efficiency. Regulatory approvals ensure clinical reliability.

Market growth is supported by integration with AI-assisted imaging. Increasing use in oncology and chronic disease diagnosis boosts adoption. Emerging markets are investing in diagnostic infrastructure. Training programs improve clinician expertise. Partnerships between imaging and device companies accelerate innovation. Image-guided biopsy remains vital for early disease detection.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/image-guided-biopsy-market?prasad

Image-Guided Biopsy Market: Major Players
Koninklijke Philips N.V, Siemens Healthcare GmbH, GE Healthcare, Brainlab, Medtronic, Olympus Corporation, Stryker, Hologic Inc.

Segment Covered in the Image-Guided Biopsy Market:
By Technology
The market is segmented into ultrasound-guided biopsy 40%, CT-guided biopsy 30%, MRI-guided biopsy 15%, and others 15%. Ultrasound-guided biopsy dominates due to real-time imaging, cost-effectiveness, and widespread availability across hospitals and diagnostic centers. CT-guided biopsy is widely used for deep-seated lesions, particularly in lung and abdominal cancers. MRI-guided biopsy is gaining traction for soft-tissue and breast applications requiring high imaging precision.

By Process
Based on process, the market includes needle biopsy 65%, surgical biopsy 20%, and vacuum-assisted biopsy 15%. Needle biopsy dominates due to its minimally invasive nature, shorter procedure time, and lower complication rates. Vacuum-assisted biopsy is increasingly adopted for accurate tissue sampling in breast and soft tissue diagnostics.

By Indication
Indication-wise, the market comprises oncology 55%, infectious diseases 15%, inflammatory diseases 15%, and others 15%. Oncology dominates due to the rising incidence of cancer and the growing need for precise tumor localization and early diagnosis. Image-guided biopsies play a critical role in personalized cancer treatment and therapy selection.

By End-User
End-user segmentation includes hospitals 50%, diagnostic imaging centers 30%, ambulatory surgical centers 15%, and others 5%. Hospitals lead due to availability of advanced imaging infrastructure and skilled interventional radiologists. Diagnostic centers are growing rapidly driven by outpatient diagnostic procedures and cost-effective imaging services.

Regional Analysis
North America - 35% Share
North America leads the market with 35% share driven by advanced diagnostic imaging infrastructure, high cancer screening rates, and early adoption of minimally invasive procedures.

Europe - 25% Share
Europe accounts for 25% share supported by strong healthcare systems, increasing cancer awareness programs, and widespread adoption of image-guided diagnostic technologies.

Asia Pacific - 22% Share
Asia Pacific holds 22% share with rising cancer prevalence, improving access to diagnostic imaging, and growing healthcare investments in China, India, and Japan.

Latin America - 10% Share
Latin America represents 10% share driven by expanding diagnostic centers and improving access to advanced biopsy procedures.

Middle East & Africa - 8% Share
Middle East & Africa accounts for 8% share supported by healthcare infrastructure development and increasing demand for advanced diagnostic procedures.

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=image-guided-biopsy-market

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.